Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
11.06. | Alignment Healthcare, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
10.06. | Alignment Healthcare Founder and CEO John Kao Named to AHIP Board | 2 | GlobeNewswire (USA) | ||
04.06. | Alignment Healthcare auf William Blair Konferenz: Datengesteuerte Medicare Advantage | 2 | Investing.com Deutsch | ||
19.05. | Alignment Healthcare USA, LLC: Alignment Health Plan Recognized as One of Two Medicare Advantage Prescription Drug Plans in the U.S. for Excellence in Pharmacy Quality | 2 | GlobeNewswire (USA) | ||
03.05. | Why Alignment Healthcare, Inc. (ALHC) Went Down On Friday | 1 | Insider Monkey | ||
01.05. | Alignment Healthcare, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
01.05. | Alignment Healthcare Reports Strong First Quarter 2025 Results; Exceeds High-End of Expectations On 4 Critical KPIs; Raises Midpoint of 2025 Guidance; Announces CFO Transition | 1.304 | GlobeNewswire (Europe) | Delivers Q1 revenue of $926.9 million, up 47.5% year over year, and grows Medicare Advantage (MA) membership by 31.7% to approximately 217,500 membersExceeds high-end of Q1 guidance on membership... ► Artikel lesen | |
ALIGNMENT HEALTHCARE Aktie jetzt für 0€ handeln | |||||
01.05. | Alignment Healthcare, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
15.04. | Alignment Healthcare, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
09.04. | Alignment Healthcare Hits 54th 52-Week High: Does It Have What It Takes to Keep Winning? | 1 | Barchart.com | ||
09.04. | Why Alignment Healthcare Inc. (ALHC) Surged On Tuesday? | 1 | Insider Monkey | ||
08.04. | Stifel raises Alignment Healthcare target to $23, maintains Buy | 3 | Investing.com | ||
08.04. | Stifel raises Alignment Healthcare target to $23 on CMS rate notice | 1 | Investing.com | ||
24.03. | Alignment Healthcare for Seniors | 2 | Barchart.com | ||
04.03. | Piper Sandler raises Alignment Healthcare target to $21, keeps Overweight | 2 | Investing.com | ||
03.03. | Raymond James lifts Alignment Healthcare target to $19 | 3 | Investing.com | ||
03.03. | Alignment Healthcare, Inc. (NASDAQ:ALHC) Q4 2024 Earnings Call Transcript | 2 | Insider Monkey | ||
28.02. | Alignment Healthcare posts $701M in quarterly revenue, beats expectations | 2 | FierceHealthcare | ||
27.02. | Alignment Healthcare Reports Fourth Quarter and Full-Year 2024 Results; Provides Full-Year 2025 Financial Guidance | 661 | GlobeNewswire (Europe) | Reports 189,100 health plan members as of Dec. 31, 2024, up 58.6% year-over-year, beating year-end expectationsAchieves first full year of positive adjusted EBITDA as a public company, driven by operating... ► Artikel lesen | |
27.02. | Alignment Healthcare, Inc. - 10-K, Annual Report | - | SEC Filings |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
SIEMENS HEALTHINEERS | 46,910 | -0,13 % | UBS stuft Siemens Healthineers auf 'Neutral' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Siemens Healthineers mit einem Kursziel von 50 Euro auf "Neutral" belassen. Die Bayern gehörten im europäischen Medtech-Bereich... ► Artikel lesen | |
GENEDX | 88,94 | 0,00 % | GeneDx price target raised to $105 from $80 at Jefferies on AAP update | ||
FRESENIUS | 42,040 | +0,21 % | EQS-PVR: Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
20.06.2025 /... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 47,700 | +0,44 % | BERENBERG stuft FMC FRESENIUS MEDICAL CARE AG auf 'Buy' | HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Fresenius Medical Care (FMC) von 55 auf 60 Euro angehoben und die Einstufung auf "Buy" belassen. Analystin Victoria Lambert... ► Artikel lesen | |
CARL ZEISS MEDITEC | 56,05 | -2,18 % | Aktienmarkt: Aktie von Carl Zeiss Meditec kann sich nicht behaupten (56,30 €) | Im deutschen Wertpapierhandel liegt die Carl Zeiss Meditec-Aktie gegenwärtig im Minus. Das Wertpapier kostete zuletzt 56,30 Euro. Ein Wertverlust in Höhe von 1,75 Euro müssen derzeit die Aktionäre von... ► Artikel lesen | |
GLUCOTRACK | 7,840 | 0,00 % | GlucoTrack Stock Jumps 40% On Strong Clinical Data For Implantable Glucose Monitor | ||
LIFEMD | 12,830 | 0,00 % | LifeMD, Inc. 8.875% CUM PFD A declares $0.5547 dividend | ||
BRIGHTSPRING HEALTH SERVICES | 22,600 | 0,00 % | BTSG Raises 2025 Financial Outlook: What's Backing It? | ||
PLUS THERAPEUTICS | 0,325 | 0,00 % | Plus Therapeutics Inc.: Plus Therapeutics Announces FDA Clearance of its Investigational New Drug Application using REYOBIQTM for the Treatment of Childhood Brain Cancer | Phase 1/2a clinical trial currently supported by a $3.0 million grant from the U.S. Department of Defense Trial will enroll children with high grade glioma and ependymoma HOUSTON, June 25, 2025... ► Artikel lesen | |
PRIVIA HEALTH GROUP | 21,740 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports First Quarter 2025 Financial Results | Strong First Quarter Performance and Operating ExecutionEnters the State of ArizonaFull-Year 2025 Outlook Raised to Mid- to High End of Guidance Ranges for All Metrics with Attributed Lives Unchanged... ► Artikel lesen | |
GOODRX | 4,905 | 0,00 % | KeyBanc Maintains Overweight Rating on GoodRx (GDRX) | ||
MIMEDX | 5,960 | 0,00 % | Positive Signal: James L Bierman Shows Faith, Buying $185K In MiMedx Group Stock | ||
GERRESHEIMER | 47,000 | +0,21 % | Gerresheimer-Aktie: Den Crash kaufen? Das könnte jetzt +138,1 Prozent und mehr bringen! | © Foto: Marek Studzinski auf UnsplashEin Minus von 35,5 Prozent ist in diesem Börsenjahr die traurige Bilanz der Gerresheimer-Aktie. Damit landet sie im deutschen Midcap-Index MDAX auf dem vorletzten... ► Artikel lesen | |
SEASTAR MEDICAL | 0,450 | 0,00 % | SeaStar Medical Reports Update on Nasdaq Listing Status | DENVER, June 25, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 58,19 | 0,00 % | PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2024 Results | SAN JOSE, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen |